Overview Financials News + Filings IR Vault Key Docs Charts Holdings Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Appointed director CC transcript Auditor change Appointed CFO
|
SCICLONE PHARMACEUTICALS INC (SCLN)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/09/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
11/07/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
11/07/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
11/07/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
11/07/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
11/07/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
11/07/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
11/07/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
11/07/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
11/07/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
11/07/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
10/31/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
10/31/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
10/31/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
10/31/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
10/31/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
10/31/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
10/31/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
10/31/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
10/31/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
10/31/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
10/31/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
10/31/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
10/31/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
10/31/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
10/31/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
10/31/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
10/31/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
10/31/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
10/31/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
10/31/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
10/31/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
10/31/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
10/17/2017 |
SC 13D/A
| Man Group plc reports a 0% stake in SciClone Pharmaceuticals, Inc. |
|
|
|